Medindia
Medindia LOGIN REGISTER
Advertisement

FASEB President Addresses Congressional Audience at Coalition for Health Funding Briefing on Public Health

Wednesday, March 3, 2010 Press Release
Advertisement


BETHESDA, Md., March 2 Federation of American Societies for Experimental Biology (FASEB) President Mark O. Lively, Ph.D., addressed a Capitol Hill audience, including congressional staff, and members of the Coalition for Health Funding (CHF) today to describe the critical role biomedical research plays in improving public health. "At a time when our nation is searching for ways to repair and improve our troubled healthcare system, I am here to reemphasize the importance of providing steady and sustained funding for biomedical research in the United States," Lively stated during the CHF-organized event titled, Public Health 101: Building Capacity to Meet America's Mounting Health Needs.
Advertisement

Lively pointed out the drastic toll chronic disease takes on both health care spending and the lives of patients suffering from these conditions. "But the good news," he added, "is that biomedical research has contributed significantly to improved health and the opportunities for continued progress have never been brighter." Lively acknowledged the challenge presented by the country's current economic situation, but reiterated the value of our investment in the National Institutes of Health (NIH). "Now is not the time to pull back from our historic commitment to investigation and discovery," he said. "Fundamental scientific discoveries funded by NIH form the basis for the ongoing transformation of the practice of medicine." He went on to list a number of NIH's recent accomplishments in advancing medicine and health, including dramatic reductions in deaths from heart disease and cancer and development of a host of new drug therapies.
Advertisement

In concluding, Lively highlighted the future promise of an accelerated pace of discovery. "We are at the beginning of a whole new era of pharmacogenomics that will identify ways to tailor treatments and scientifically match therapies to individuals," he declared, describing how advances in genomic sequencing have already led to the dawn of personalized medicine. "Continued progress towards that goal depends on sustained and predictable funding support for NIH... one critical part of the prescription for improved health. Research means hope."

For the full transcript of Lively's remarks, please see: http://opa1.faseb.org/pages/LG/livelyCHFspeech.htm

FASEB is composed of 23 societies with more than 90,000 members, making it the largest coalition of biomedical research associations in the United States. FASEB enhances the ability of scientists and engineers to improve -- through their research -- the health, well-being and productivity of all people. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.

SOURCE Federation of American Societies for Experimental Biology
Sponsored Post and Backlink Submission


This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close